BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Livne O, Shmulewitz D, Lev-Ran S, Hasin DS. DSM-5 cannabis withdrawal syndrome: Demographic and clinical correlates in U.S. adults. Drug Alcohol Depend 2019;195:170-7. [PMID: 30361043 DOI: 10.1016/j.drugalcdep.2018.09.005] [Cited by in Crossref: 46] [Cited by in F6Publishing: 44] [Article Influence: 11.5] [Reference Citation Analysis]
Number Citing Articles
1 Yeap ZJS, Marsault J, George TP, Mizrahi R, Rabin RA. Does tobacco dependence worsen cannabis withdrawal in people with and without schizophrenia-spectrum disorders? Am J Addict 2023. [PMID: 36815595 DOI: 10.1111/ajad.13394] [Reference Citation Analysis]
2 Hajjar ER, Lungen JM, Worster BK. Therapeutic Benefits of Medical Cannabis. Physician Assistant Clinics 2022. [DOI: 10.1016/j.cpha.2022.10.008] [Reference Citation Analysis]
3 Winer JM, Yule AM, Hadland SE, Bagley SM. Addressing adolescent substance use with a public health prevention framework: the case for harm reduction. Ann Med 2022;54:2123-36. [PMID: 35900132 DOI: 10.1080/07853890.2022.2104922] [Reference Citation Analysis]
4 Sorkhou M, Johnstone S, Kivlichan AE, Castle DJ, George TP. Does cannabis use predict aggressive or violent behavior in psychiatric populations? A systematic review. Am J Drug Alcohol Abuse 2022;48:631-43. [PMID: 36137273 DOI: 10.1080/00952990.2022.2118060] [Reference Citation Analysis]
5 Bahji A, Gorelick DA. Factors Associated With Past-year and Lifetime Prevalence of Cannabis Withdrawal: A Secondary Analysis. Canadian Journal of Addiction 2022;13:14-25. [DOI: 10.1097/cxa.0000000000000155] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Kurt Tunagur EM, Yazici AB, Guzel D, Tunagur MT, Ermis C, Suda MA, Yazici E. Investigating associations between appetite-regulating hormones, aggression and craving in males with cannabis use disorder. Drug Alcohol Depend 2022;238:109577. [PMID: 35905593 DOI: 10.1016/j.drugalcdep.2022.109577] [Reference Citation Analysis]
7 Holdman R. Evidence of Health Effects Associated with Marijuana Use: A Comprehensive Public Health Review. Cannabinoids - Recent Perspectives and Applications in Human Health [Working Title] 2022. [DOI: 10.5772/intechopen.106250] [Reference Citation Analysis]
8 DeJong KN, Choby B, Valent AM. Strategies for Prevention or Treatment of Tobacco and Cannabis Use Disorder. Clin Obstet Gynecol 2022;65:397-419. [PMID: 35318983 DOI: 10.1097/GRF.0000000000000688] [Reference Citation Analysis]
9 Asper A, Feingold D, Binenfeld E, Pshitizky H. Sociodemographic and clinical correlates of cannabis dependence among Israeli combat veterans. Journal of Substance Abuse Treatment 2022. [DOI: 10.1016/j.jsat.2022.108786] [Reference Citation Analysis]
10 Hulvershorn LA, Adams ZW, Smoker MP, Aalsma MC, Gibbons RD. Development of a computerized adaptive substance use disorder scale for screening, measurement and diagnosis - The CAT-SUD-E. Drug Alcohol Depend Rep 2022;3:100047. [PMID: 36845991 DOI: 10.1016/j.dadr.2022.100047] [Reference Citation Analysis]
11 Livne O, Feinn R, Knox J, Hartwell EE, Gelernter J, Hasin DS, Kranzler HR. Alcohol withdrawal in past-year drinkers with unhealthy alcohol use: Prevalence, characteristics, and correlates in a national epidemiologic survey. Alcohol Clin Exp Res 2022;46:422-33. [PMID: 35275407 DOI: 10.1111/acer.14781] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Laudanski K, Wain J. Considerations for Cannabinoids in Perioperative Care by Anesthesiologists. J Clin Med 2022;11:558. [PMID: 35160010 DOI: 10.3390/jcm11030558] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Murray H, Thant T. Cannabis in the Adult Medical and Consultation-Liaison Settings. Cannabis in Psychiatric Practice 2022. [DOI: 10.1007/978-3-031-04874-6_14] [Reference Citation Analysis]
14 Schecter D, Cyr C. Choosing a Product, Route of Administration, Initial Dosage, Titration, Monitoring and Management of Adverse Effects. Cannabis and Cannabinoid-Based Medicines in Cancer Care 2022. [DOI: 10.1007/978-3-030-89918-9_7] [Reference Citation Analysis]
15 Craft S, Ferris JA, Barratt MJ, Maier LJ, Lynskey MT, Winstock AR, Freeman TP. Clinical withdrawal symptom profile of synthetic cannabinoid receptor agonists and comparison of effects with high potency cannabis. Psychopharmacology (Berl) 2022;239:1349-57. [PMID: 34533608 DOI: 10.1007/s00213-021-05945-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Zawilska JB, Kuczyńska K, Bratzu J, Fattore L. Neurotoxicity of Exogenous Cannabinoids. Handbook of Neurotoxicity 2022. [DOI: 10.1007/978-3-031-15080-7_206] [Reference Citation Analysis]
17 Coughlin LN, Ilgen MA, Jannausch M, Walton MA, Bohnert KM. Progression of cannabis withdrawal symptoms in people using medical cannabis for chronic pain. Addiction 2021;116:2067-75. [PMID: 33400332 DOI: 10.1111/add.15370] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
18 Shi Z, Jagannathan K, Padley JH, Wang AL, Fairchild VP, O'Brien CP, Childress AR, Langleben DD. The role of withdrawal in mesocorticolimbic drug cue reactivity in opioid use disorder. Addict Biol 2021;26:e12977. [PMID: 33098179 DOI: 10.1111/adb.12977] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
19 Stewart C, Fong Y. Concerns about Recommendations for Perioperative Cannabis Use-Reply. JAMA Surg 2021. [PMID: 34132757 DOI: 10.1001/jamasurg.2021.2265] [Reference Citation Analysis]
20 Mullins MF. Cannabis dabbing: An emerging trend. Nursing 2021;51:46-50. [PMID: 33871423 DOI: 10.1097/01.NURSE.0000743108.72528.d8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
21 Marín J, Pérez de Mendiola X, Fernández S, Chart JP. Cannabis withdrawal induced brief psychotic disorder: a case study during the national lockdown secondary to the COVID-19 pandemic. J Addict Dis 2021;:1-8. [PMID: 33884940 DOI: 10.1080/10550887.2021.1910473] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
22 Eckard ML, Kinsey SG. Gabapentin attenuates somatic signs of precipitated THC withdrawal in mice. Neuropharmacology 2021;190:108554. [PMID: 33845073 DOI: 10.1016/j.neuropharm.2021.108554] [Reference Citation Analysis]
23 Hasin D, Walsh C. Trends over time in adult cannabis use: A review of recent findings. Curr Opin Psychol 2021;38:80-5. [PMID: 33873044 DOI: 10.1016/j.copsyc.2021.03.005] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 7.0] [Reference Citation Analysis]
24 Connor JP, Stjepanović D, Le Foll B, Hoch E, Budney AJ, Hall WD. Cannabis use and cannabis use disorder. Nat Rev Dis Primers 2021;7:16. [PMID: 33627670 DOI: 10.1038/s41572-021-00247-4] [Cited by in Crossref: 68] [Cited by in F6Publishing: 68] [Article Influence: 34.0] [Reference Citation Analysis]
25 Takakuwa KM, Schears RM. The emergency department care of the cannabis and synthetic cannabinoid patient: a narrative review. Int J Emerg Med 2021;14:10. [PMID: 33568074 DOI: 10.1186/s12245-021-00330-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
26 Serebro M, Sobol-Goldberg S, Feingold D. From Enchantment to Disillusion: A Narrative Exploration of Cannabis Use Disorder Among Young Israeli Combat Veterans. Front Psychiatry 2021;12:643618. [PMID: 34220568 DOI: 10.3389/fpsyt.2021.643618] [Reference Citation Analysis]
27 Kayser RR, Haney M, Simpson HB. Human Laboratory Models of Cannabis Use: Applications for Clinical and Translational Psychiatry Research. Front Psychiatry 2021;12:626150. [PMID: 33716825 DOI: 10.3389/fpsyt.2021.626150] [Reference Citation Analysis]
28 Wallach J. Medicinal Cannabis: an overview for health-care providers. Remington 2021. [DOI: 10.1016/b978-0-12-820007-0.00005-2] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
29 Zawilska JB, Kuczyńska K, Bratzu J, Fattore L. Neurotoxicity of Exogenous Cannabinoids. Handbook of Neurotoxicity 2021. [DOI: 10.1007/978-3-030-71519-9_206-1] [Reference Citation Analysis]
30 Hasin D, Walsh C. Cannabis Use, Cannabis Use Disorder, and Comorbid Psychiatric Illness: A Narrative Review. J Clin Med 2020;10:E15. [PMID: 33374666 DOI: 10.3390/jcm10010015] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 6.3] [Reference Citation Analysis]
31 Buck JS, Bloomer AK, Wally MK, Seymour RB, Hsu JR. The Current Evidence for Marijuana as Medical Treatment. J Bone Joint Surg Am 2020;102:2096-105. [PMID: 33264218 DOI: 10.2106/JBJS.20.00269] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
32 Dervaux A, De Carvalho C, Cottencin O. Troubles anxieux, troubles dépressifs, conduites suicidaires et cannabis. La Presse Médicale Formation 2020;1:384-393. [DOI: 10.1016/j.lpmfor.2020.09.015] [Reference Citation Analysis]
33 Feingold D, Brill S, Goor-Aryeh I, Delayahu Y, Lev-Ran S. Depression level, not pain severity, is associated with smoked medical marijuana dosage among chronic pain patients. J Psychosom Res 2020;135:110130. [PMID: 32417435 DOI: 10.1016/j.jpsychores.2020.110130] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
34 Calcaterra SL, Cunningham CO, Hopfer CJ. The Void in Clinician Counseling of Cannabis Use. J Gen Intern Med 2020;35:1875-8. [PMID: 31898125 DOI: 10.1007/s11606-019-05612-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
35 Campeny E, López-Pelayo H, Nutt D, Blithikioti C, Oliveras C, Nuño L, Maldonado R, Florez G, Arias F, Fernández-Artamendi S, Villalbí JR, Sellarès J, Ballbè M, Rehm J, Balcells-Olivero MM, Gual A. The blind men and the elephant: Systematic review of systematic reviews of cannabis use related health harms. Eur Neuropsychopharmacol 2020;33:1-35. [PMID: 32165103 DOI: 10.1016/j.euroneuro.2020.02.003] [Cited by in Crossref: 64] [Cited by in F6Publishing: 57] [Article Influence: 21.3] [Reference Citation Analysis]
36 Bahji A, Stephenson C, Tyo R, Hawken ER, Seitz DP. Prevalence of Cannabis Withdrawal Symptoms Among People With Regular or Dependent Use of Cannabinoids: A Systematic Review and Meta-analysis. JAMA Netw Open 2020;3:e202370. [PMID: 32271390 DOI: 10.1001/jamanetworkopen.2020.2370] [Cited by in Crossref: 73] [Cited by in F6Publishing: 65] [Article Influence: 24.3] [Reference Citation Analysis]
37 Feingold D, Livne O, Rehm J, Lev-Ran S. Probability and correlates of transition from cannabis use to DSM-5 cannabis use disorder: Results from a large-scale nationally representative study. Drug Alcohol Rev 2020;39:142-51. [PMID: 31916333 DOI: 10.1111/dar.13031] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 8.0] [Reference Citation Analysis]
38 Brooks E, Sørheim SE. Looking at Marijuana Through the Lens of Public Health. Cannabis in Medicine 2020. [DOI: 10.1007/978-3-030-45968-0_18] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
39 Claus BB, Specka M, McAnally H, Scherbaum N, Schifano F, Bonnet U. Is the Urine Cannabinoid Level Measured via a Commercial Point-of-Care Semiquantitative Immunoassay a Cannabis Withdrawal Syndrome Severity Predictor? Front Psychiatry 2020;11:598150. [PMID: 33343424 DOI: 10.3389/fpsyt.2020.598150] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
40 Hamilton I, Tracy D. Problems with defining cannabis dependence. Curr Opin Psychiatry 2020;33:14-9. [PMID: 31634166 DOI: 10.1097/YCO.0000000000000561] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
41 Fatima H, Howlett AC, Whitlow CT. Reward, Control & Decision-Making in Cannabis Use Disorder: Insights from Functional MRI. Br J Radiol 2019;92:20190165. [PMID: 31364398 DOI: 10.1259/bjr.20190165] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
42 Green KM, Arria AM. Commentary on Terry-McElrath et al. (2019): Will persistent patterns of youth marijuana use compromise their futures? Addiction 2019;114:1049-50. [PMID: 31012163 DOI: 10.1111/add.14612] [Reference Citation Analysis]
43 Hasin DS, Shmulewitz D, Sarvet AL. Time trends in US cannabis use and cannabis use disorders overall and by sociodemographic subgroups: a narrative review and new findings. Am J Drug Alcohol Abuse 2019;45:623-43. [PMID: 30870044 DOI: 10.1080/00952990.2019.1569668] [Cited by in Crossref: 81] [Cited by in F6Publishing: 70] [Article Influence: 20.3] [Reference Citation Analysis]
44 Beaudoin M, Potvin S, Dellazizzo L, Luigi M, Giguère CE, Dumais A. Trajectories of Dynamic Risk Factors as Predictors of Violence and Criminality in Patients Discharged From Mental Health Services: A Longitudinal Study Using Growth Mixture Modeling. Front Psychiatry 2019;10:301. [PMID: 31139099 DOI: 10.3389/fpsyt.2019.00301] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]